153 related articles for article (PubMed ID: 2348598)
1. Increased erythrophagocytic activity of macrophages in dogs with Babesia gibsoni infection.
Murase T; Maede Y
Nihon Juigaku Zasshi; 1990 Apr; 52(2):321-7. PubMed ID: 2348598
[TBL] [Abstract][Full Text] [Related]
2. Clinical and hematologic effects of experimental infection of dogs with recently identified Babesia gibsoni-like isolates from Oklahoma.
Meinkoth JH; Kocan AA; Loud SD; Lorenz MD
J Am Vet Med Assoc; 2002 Jan; 220(2):185-9. PubMed ID: 12126127
[TBL] [Abstract][Full Text] [Related]
3. The effect of macrophages on the erythrocyte oxidative damage and the pathogenesis of anemia in Babesia gibsoni-infected dogs with low parasitemia.
Otsuka Y; Yamasaki M; Yamato O; Maede Y
J Vet Med Sci; 2002 Mar; 64(3):221-6. PubMed ID: 11999441
[TBL] [Abstract][Full Text] [Related]
4. Serum hemolytic activity in dogs infected with Babesia gibsoni.
Onishi T; Ueda K; Horie M; Kajikawa T; Ohishi I
J Parasitol; 1990 Aug; 76(4):564-7. PubMed ID: 2380866
[TBL] [Abstract][Full Text] [Related]
5. Elevated erythrocyte-bound IgG value in dogs with clinical Babesia gibsoni infection.
Adachi K; Tateishi M; Horii Y; Nagatomo H; Shimizu T; Makimura S
J Vet Med Sci; 1994 Aug; 56(4):757-9. PubMed ID: 7999903
[TBL] [Abstract][Full Text] [Related]
6. Some observations on experimentally induced infection of dogs with Babesia gibsoni.
Botros BA; Moch RW; Barsoum IS
Am J Vet Res; 1975 Mar; 36(3):293-6. PubMed ID: 1115427
[TBL] [Abstract][Full Text] [Related]
7. Use of a doxycycline-enrofloxacin-metronidazole combination with/without diminazene diaceturate to treat naturally occurring canine babesiosis caused by Babesia gibsoni.
Lin MY; Huang HP
Acta Vet Scand; 2010 Apr; 52(1):27. PubMed ID: 20416095
[TBL] [Abstract][Full Text] [Related]
8. Clinical, anatomic, and immunopathologic characterization of Babesia gibsoni infection in the domestic dog (Canis familiaris).
Wozniak EJ; Barr BC; Thomford JW; Yamane I; McDonough SP; Moore PF; Naydan D; Robinson TW; Conrad PA
J Parasitol; 1997 Aug; 83(4):692-9. PubMed ID: 9267413
[TBL] [Abstract][Full Text] [Related]
9. Changes in anti-erythrocyte membrane antibody level of dogs experimentally infected with Babesia gibsoni.
Adachi K; Makimura S
J Vet Med Sci; 1992 Dec; 54(6):1221-3. PubMed ID: 1477177
[TBL] [Abstract][Full Text] [Related]
10. Hemolytic anemia caused by Babesia gibsoni infection in dogs.
Conrad P; Thomford J; Yamane I; Whiting J; Bosma L; Uno T; Holshuh HJ; Shelly S
J Am Vet Med Assoc; 1991 Sep; 199(5):601-5. PubMed ID: 1787120
[TBL] [Abstract][Full Text] [Related]
11. Electron microscopic study of canine Babesia gibsoni infection.
Radi ZA; Styer EL; Frazier KS
J Vet Diagn Invest; 2004 May; 16(3):229-33. PubMed ID: 15152839
[TBL] [Abstract][Full Text] [Related]
12. Oxidative damage and enhanced erythrophagocytosis in canine erythrocytes infected with Babesia gibsoni.
Murase T; Ueda T; Yamato O; Tajima M; Maede Y
J Vet Med Sci; 1996 Mar; 58(3):259-61. PubMed ID: 8777235
[TBL] [Abstract][Full Text] [Related]
13. Changes of serum hemolytic activity and the number of reticulocytes in canine Babesia gibsoni-infection.
Onishi T; Suzuki S
J Vet Med Sci; 1994 Jun; 56(3):611-2. PubMed ID: 7948407
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte oxidation in artificial Babesia gibsoni infection.
Morita T; Saeki H; Imai S; Ishii T
Vet Parasitol; 1996 May; 63(1-2):1-7. PubMed ID: 8792575
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo safety and efficacy studies of amphotericin B on Babesia gibsoni.
Yamasaki M; Harada E; Tamura Y; Lim SY; Ohsuga T; Yokoyama N; Morishita K; Nakamura K; Ohta H; Takiguchi M
Vet Parasitol; 2014 Oct; 205(3-4):424-33. PubMed ID: 25260334
[TBL] [Abstract][Full Text] [Related]
16. Clindamycin in the treatment of Babesia gibsoni infections in dogs.
Wulansari R; Wijaya A; Ano H; Horii Y; Nasu T; Yamane S; Makimura S
J Am Anim Hosp Assoc; 2003; 39(6):558-62. PubMed ID: 14736722
[TBL] [Abstract][Full Text] [Related]
17. Morphological changes of Babesia gibsoni grown in canine red blood cell-substituted severe combined immune deficiency mice.
Fukumoto S; Xuan X; Igarashi I; Zhang S; Mugisha J; Ogata T; Nagasawa H; Fujisaki K; Suzuki N; Mikami T
J Parasitol; 2000 Oct; 86(5):956-8. PubMed ID: 11128518
[TBL] [Abstract][Full Text] [Related]
18. Antiprotozoal treatment of canine babesiosis.
Baneth G
Vet Parasitol; 2018 Apr; 254():58-63. PubMed ID: 29657012
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro.
Matsuu A; Koshida Y; Kawahara M; Inoue K; Ikadai H; Hikasa Y; Okano S; Higuchi S
Vet Parasitol; 2004 Sep; 124(1-2):9-18. PubMed ID: 15350657
[TBL] [Abstract][Full Text] [Related]
20. First description of the pathogenicity of Babesia vogeli in experimentally infected dogs.
Wang J; Zhang J; Kelly P; Zheng X; Li M; You J; Huang K; Qiu H; Wang Y; Zhang R; Li J; Dong J; Feng Y; Zhou J; Wang C
Vet Parasitol; 2018 Apr; 253():1-7. PubMed ID: 29604992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
